Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Vertex Pharmaceuticals, Inc. (NQ: VRTX)
78.43 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Vertex Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
61 62 Next >
NASDAQ Gainers Watch List: Alkermes plc (NASDAQ:ALKS), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Pharmacyclics Inc. (NASDAQ:PCYC) Added to Growing Stock Report's NASDAQ Gainers Watch List
May 22, 2013
New York, NY -- (SBWIRE) -- 05/22/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Alkermes plc (NASDAQ:ALKS), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and... Read More
from SBWire - Latest Press Releases
NASDAQ Gainers Watch List: Alkermes plc (NASDAQ:ALKS), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), and Pharmacyclics Inc. (NASDAQ:PCYC) Added to Equity Profile Report's NASDAQ Gainers Watch Lis
May 21, 2013
Wilmington, DE -- (SBWIRE) -- 05/21/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Alkermes plc (NASDAQ:ALKS), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), and... Read More
from SBWire - Latest Press Releases
$307,000-a-year Vertex Drug: Billions in Sales?
May 20, 2013
category VRTX
from YCharts
Earnings Look Back: Vertex Pharmaceuticals Is Up 3.5% Since Reporting Quarterly Results 2 Weeks Ago (VRTX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Pharma's R&D Deals With Foundations May Negatively Impact Image
May 20, 2013
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), in their attempts to accelerate the discovery and development of... Read More
category NASDAQ:VRTX , NYSE:PFE
from Forbes Real Time
Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
May 17, 2013
from Business Wire News Releases
MDY, VRTX, KSU, AME: Large Inflows Detected at ETF
May 16, 2013
Symbols mentioned in this story: MDY, VRTX, KSU, AME Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
NASDAQ 100 Mid-day Update: Flat Top Performers: NFLX, NIHD, SIRI
May 15, 2013
New York, May 15th (TradersHuddle.com) - The NASDAQ 100 Index is flat trading at 0, which represents 0% versus its previous close. The index is mixed for the day with slightly more than 50% of its... Read More
from TradersHuddle.com
(MRK) Merck & Company Joins Forces With Bristol-Myers Squibb on Hepatitis C Virus Candidates
May 14, 2013
Merck & Co. Inc. (MRK) recently joined forces with Bristol-Myers Squibb (BMY) to conduct a... Visit StockBlogHub to view complete post. Read More
category Transcept Pharmaceuticals Inc , Cleveland BioLabs Inc , CBLI , and 9 more.
from Stock Blog Hub
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Vertex Pharmaceuticals Crosses Above its 10-day MA (VRTX)
May 10, 2013
from Comtex SmarTrend® News Briefs
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
May 09, 2013
from Business Wire News Releases
Orphan Drug Companies Might Not Find A Parent
May 08, 2013
by Olga Oksman Read More
category NASDAQ:VRTX , EURONEXTPARIS:SNY , NASDAQ:NPSP , and 2 more.
from Forbes Real Time
MDY, VRTX, REGN, KSU: ETF Outflow Alert
May 08, 2013
Symbols mentioned in this story: MDY, VRTX, REGN, KSU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Many in U.S. don't get proper testing for hepatitis C- CDC
May 07, 2013
NEW YORK, May 7 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, U.S. health officials said on... Read More
category companyNews
from Reuters: Company News
Midcaps Double S&P 500 Return: Get the Right ETF
May 07, 2013
category O , REGN , GE , and 10 more.
from YCharts
NASDAQ Gainers Watch List: MannKind Corp. (NASDAQ:MNKD), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), and Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Added to Growing Stock Report's NASDAQ Gainers
May 07, 2013
New York, NY -- (SBWIRE) -- 05/07/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding MannKind Corp. (NASDAQ:MNKD), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), and... Read More
from SBWire - Latest Press Releases
NASDAQ 100 Round Up - Flat: BIDU, CTRP, VRTX
May 06, 2013
New York, May 6th (TradersHuddle.com) - The NASDAQ 100 Index is flat trading at 0, which represents 0% versus its previous close. The index is mixed for the day with slightly more than 50% of its... Read More
from TradersHuddle.com
Big Profits in Big Pharma
May 06, 2013
Don't let the less-than-stellar first quarter performances of a few well-known drug makers spook you: "Big Pharma" is a good investment over the long haul. Read More
from Update Content Feed for Financial Content
NASDAQ 100's Top Performers: GILD, ERTS, PCAR
May 03, 2013
New York, May 3rd (TradersHuddle.com) - The NASDAQ 100 Index is higher trading at 2949.52, which represents 1.32% versus its previous close. The index is mixed for the day with slightly more than 50%... Read More
from TradersHuddle.com
EPR adds FB, ARNA and VRTX to their Nasdaq Active Stock Watch List
May 03, 2013
from ACCESSWIRE
Free Research Reports on AVEO, CXO, MWW and VRTX Issued by the Paragon Report
May 03, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The... Read More
category GALE , NVS , ONXX , and 17 more.
from Bio-Wire.Com
Vertex (VRTX) VX-135 Looks Interesting, Thinks Deutsche Bank
May 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8299701 for the full story. Read More
from StreetInsider.com News Articles
NASDAQ Gainers Watch List: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Synacor, Inc. (NASDAQ:SYNC) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 01, 2013
New York, NY -- (SBWIRE) -- 05/01/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Synacor, Inc. (NASDAQ:SYNC). Read More
from SBWire - Latest Press Releases
AFFY, AMGN, VRTX, and QCOR Early Briefing and Review
May 01, 2013
from ACCESSWIRE
Benzinga Market Primer: Wednesday, May 1
May 01, 2013
Futures Higher Ahead of Key Economic Data, Earnings U.S. equity futures rose in early pre-market trade ahead of key earnings and economic data. The FOMC rate decision and policy statement is due out... Read More
category Earnings , Benzinga , Global , and 48 more.
from Latest Articles from Benzinga.com
UPDATE 2-Vertex posts loss, raises cystic fibrosis sales view
April 30, 2013
April 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday increased by $20 million the 2013 forecast for sales of its cystic fibrosis drug that has become the focus for investors, and its shares rose... Read More
category companyNews
from Reuters: Company News
Vertex posts quarterly loss as hepatitis C drug sales fall
April 30, 2013
April 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company... Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
61 62 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Random Thoughts: A Signal That Bears Watching
Todd Harrison
2
Random Thoughts: The Chasm Between Stocks and Commodities Continues to Widen
Todd Harrison
3
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
4
Apple: Stock Charts Show It May Be Ready for a Reaction Rally
Jason Haver
5
The 10 Trading Commandments
Todd Harrison

Financial Product Guide